Author: Assi, M.; Koshy, K. M.; El Atrouni, W.; Burke, K.; Berg, M.; Opardija, A.; Temesgen, Z.
Title: Investigational immunomodulatory therapies for COVID-19 Cord-id: wxkgqpu6 Document date: 2021_1_1
ID: wxkgqpu6
Snippet: A large number of candidate drugs are undergoing evaluation for their potential to modulate the pathologic host immune response to SARS-CoV-2 infection. Clinical trial efficacy and safety data are slowly emerging for several of these agents. We provide a summary of candidate immunomodulatory agents, which are registered in ClinicalTrials.gov , and for which clinical data are available. We provide the rationale for their consideration for the treatment of COVID-19, as well as report on data avail
Document: A large number of candidate drugs are undergoing evaluation for their potential to modulate the pathologic host immune response to SARS-CoV-2 infection. Clinical trial efficacy and safety data are slowly emerging for several of these agents. We provide a summary of candidate immunomodulatory agents, which are registered in ClinicalTrials.gov , and for which clinical data are available. We provide the rationale for their consideration for the treatment of COVID-19, as well as report on data available from the various clinical investigations of their efficacy and safety.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date